SECURITIES AND EXCHANGE COMMISSION
================================================================================
                             Washington, D.C. 20549

                             ----------------------

                                    FORM 10-Q

(Mark One)

[X]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
     ACT OF 1934 for the quarterly period ended June 30, 1998

                                       OR

[_]  TRANSITION  REPORT  PURSUANT  TO  SECTION  13 OR  15(d)  OF THE  SECURITIES
     EXCHANGE  ACT  OF  1934  for  the  transition  period  from  __________  to
     __________


                        Commission file number: 000-22673


                            SCHICK TECHNOLOGIES, INC.
             (Exact name of registrant as specified in its charter)

          Delaware                                         11-3374812
(State or other jurisdiction of                          (I.R.S. Employer      
incorporation or organization)                           Identification Number)
                                                                


          31-00 47th Avenue                                    11101
     Long Island City, New York                              (Zip Code)
(Address of principal executive offices)

       Registrant's telephone number, including area code: (718) 937-5765

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. Yes [X] No [_]

As of August 5, 1998, 9,992,566 shares of common stock, par value $.01 per
share, were outstanding.

================================================================================

<PAGE>


                            SCHICK TECHNOLOGIES, INC.

                                TABLE OF CONTENTS


<TABLE>
<S>                                                                         <C>
PART I.  FINANCIAL INFORMATION:

     Item 1.  Financial Statements:

              Consolidated Balance Sheet as of June 30, 1998 and
              March 31, 1998 ............................................   Page 1

              Consolidated Statement of Operations for the three months
              ended June 30, 1998 and 1997 ..............................   Page 2

              Consolidated Statement of Cash Flows for the three
              months ended June 30, 1998 and 1997 .......................   Page 3

              Notes to Consolidated Financial Statements ................   Page 4
     Item 2.  Management's Discussion and Analysis of Financial Condition
                       And Results of Operations ........................   Page 6
PART II.  OTHER INFORMATION:
     Item 2.  Changes in Securities and Use of  Proceeds ................   Page 8
     Item 6.  Exhibits and Reports on Form 8-K ..........................   Page 8
SIGNATURE ...............................................................   Page 9
EXHIBIT 27 ..............................................................   Page 10
</TABLE>


<PAGE>





PART I. Financial Information
Item 1. Financial Statements

                            Schick Technologies, Inc.
                           Consolidated Balance Sheet
                      (In thousands , except share amounts)

<TABLE>
<CAPTION>
                       Assets                                           June 30, 1998      March 31, 1998
                                                                        -----------        --------------
                                                                        (unaudited)
<S>                                                                     <C>                   <C>    
Current assets
  Cash and cash equivalents                                             $ 1,649               $ 6,217
  Short-term investments                                                 13,933                14,022
  Accounts receivable, net of allowance for doubtful
   accounts of  $330 and $200,  respectively                             14,450                10,173
  Inventories                                                            13,303                12,152
  Prepayments and other current assets                                      531                   746
                                                                        -------               -------
         Total current assets                                            43,866                43,310

Equipment, net                                                            6,458                 5,801
Investments                                                               1,000                 1,000
Other assets                                                              1,265                 1,214
Deferred tax asset                                                          120                   349
                                                                        -------               -------

         Total assets                                                   $52,709               $51,674
                                                                        =======               =======

       Liabilities and Stockholders' Equity

Current liabilities
  Accounts payable and accrued expenses                                 $ 6,265               $ 7,010
  Accrued salaries and commissions                                        1,516                 1,473
  Provision for warranty obligations                                        258                   245
  Income taxes payable                                                      292                   144
  Deferred revenue                                                          339                   362
  Deposits from customers                                                   442                   331
                                                                        -------               -------
         Total current liabilities                                        9,112                 9,565


Commitments                                                                  --                    --

Stockholders' equity
  Preferred stock ($.01 par value; 2,500,000 shares
   authorized, none issued and outstanding)                                  --                    --
  Common stock ($.01 par value; 25,000,000 shares
   authorized; 9,992,566 and 9,992,057 shares issued
   and outstanding)                                                         100                   100
  Additional paid-in capital                                             41,208                41,204
  Retained earnings                                                       2,289                   805
                                                                        -------               -------
         Total stockholders' equity                                      43,597                42,109

           Total liabilities and stockholders' equity                   $52,709               $51,674
                                                                        =======               =======
</TABLE>

  The accompanying notes are an integral part of these consolidated financial
                                  statements.

                                       1

<PAGE>


                            Schick Technologies, Inc.
                      Consolidated Statement of Operations
                    (In thousands, except per share amounts)
                                   (unaudited)

<TABLE>
<CAPTION>
                                                     Three months ended June 30,
                                                     ---------------------------
                                                           1998          1997
                                                           ----          ----

<S>                                                       <C>           <C>    
Revenues, net                                             $15,980       $ 6,040
Cost of sales                                               7,217         2,831
                                                          -------       -------
     Gross profit                                           8,763         3,209
                                                          -------       -------

Operating expenses
  Selling and marketing                                     4,157         1,795
  General and administrative                                1,350           878
  Research and development                                  1,033           638
  Patent litigation settlement                                 --           600
                                                          -------       -------
     Total operating expenses                               6,540         3,911
                                                          -------       -------

     Income (loss) from operations                          2,223          (702)
                                                          -------       -------

Other income (expense)
   Interest income                                            243            48
   Interest expense                                            --           (43)
                                                          -------       -------

     Total other income (expense)                             243             5

     Income (loss) before income taxes                      2,466          (697)
                                                          -------       -------

Provision for income taxes                                    983            --
                                                              

Net income (loss)                                         $ 1,483       $  (697)
                                                          =======       =======

Basic earnings (loss) per share                           $  0.15       $  (.09)
                                                          =======       =======

Diluted  earnings (loss) per share                        $  0.14       $  (.09)
                                                          =======       =======
</TABLE>


  The accompanying notes are an integral part of these consolidated financial
                                  statements.

                                       2

<PAGE>



                            Schick Technologies, Inc.
                      Consolidated Statement of Cash Flows
                                 (In thousands)
                                   (unaudited)

<TABLE>
<CAPTION>
                                                             Three months ended June 30,
                                                             ---------------------------
                                                                  1998       1997
                                                                  ----       ----
<S>                                                             <C>        <C>     
Net cash flows from operating activities:
Net income (loss)                                               $ 1,483    $  (697)
Adjustments to reconcile net income (loss) to net cash
  (used in) provided by operating activities
   Depreciation and amortization                                    431        125
   Stock and option grant compensation                               --          5

   Accrued interest on investments                                 (182)        14
Changes in assets and liabilities:
  Accounts receivable                                            (4,277)      (635)
  Inventories                                                    (1,151)    (2,183)
  Prepayments and other current assets                              266         47
  Other assets                                                      (96)       (29)
  Deferred income taxes                                             229         --
  Accounts payable and accrued expenses                            (689)     3,312
  Income taxes payable                                              148         --
  Deferred revenue                                                  (23)        58
  Deposits from customers                                           112         (6)
  Accrued interest on notes payable                                  --         39
                                                                -------    -------
       Net cash (used in) provided by operating activities       (3,749)        50
                                                                -------    -------

Cash flows from investing activities:
  Capitalization of software development costs                      (50)        --
  Purchases of held-to-maturity investments                      (1,196)      (101)
  Proceeds from maturities of held-to-maturity investments        1,466        642
  Capital expenditures                                           (1,043)      (663)
                                                                -------    -------
           Net cash used in investing activities                   (823)      (122)
                                                                -------    -------

Cash flows from financing activities:
  Proceeds from exercise of common stock options                      4         --
  Deferred offering costs                                            --       (977)
  Principal payments on capital lease obligations                    --         (5)
                                                                -------    -------
          Net cash provided by (used in) financing activities         4       (982)
                                                                -------    -------

Net decrease  in cash and cash equivalents                       (4,568)    (1,054)
Cash and cash equivalents at beginning of period                  6,217      1,710
                                                                -------    -------

Cash and cash equivalents at end of period                      $ 1,649    $   656
                                                                =======    =======
</TABLE>


  The accompanying notes are an integral part of these consolidated financial
                                  statements.

                                       3

<PAGE>


                            Schick Technologies, Inc.
             Notes to Consolidated Financial Statements (unaudited)
               (in thousands, except share and per share amounts)
--------------------------------------------------------------------------------

1.   Basis of Presentation

     The consolidated financial statements of Schick Technologies,  Inc. and its
     subsidiaries  (collectively the "Company") have been prepared in accordance
     with  generally  accepted  accounting   principles  for  interim  financial
     information  and the rules of the Securities and Exchange  Commission  (the
     "SEC") for  quarterly  reports on Form 10-Q,  and do not include all of the
     information  and  footnote   disclosures  required  by  generally  accepted
     accounting principles for complete financial  statements.  These statements
     should  be read in  conjunction  with the  audited  consolidated  financial
     statements and notes thereto for the year ended March 31, 1998, included in
     the Company's Annual report on form 10-K.

     In the  opinion of  management,  the  accompanying  unaudited  consolidated
     financial  statements  include  all  adjustments   (consisting  of  normal,
     recurring  adjustments)  necessary  for a fair  presentation  of results of
     operations for the interim periods. The results of operations for the three
     months ended June 30, 1998, are not  necessarily  indicative of the results
     to be expected for the full year ending March 31, 1999.

     The  consolidated  financial  statements of the Company,  at June 30, 1998,
     include the accounts of the Company and its wholly owned subsidiaries.  All
     significant intercompany balances have been eliminated.

2.   Inventories

     Inventories  at June 30,  1998 and  March  31,  1998 are  comprised  of the
     following:

<TABLE>
<CAPTION>
                                                June 30, 1998     March 31, 1998
                                                -------------     --------------
<S>                                               <C>               <C>    
      Raw materials .........................     $ 6,904           $ 7,108
      Work-in-process .......................       4,648             3,466
      Finished goods ........................       1,751             1,578
                                                  -------           -------
          Total inventories .................     $13,303           $12,152
                                                  =======           =======
</TABLE>

3.   Initial Public Offering

     In July 1997,  the Company  completed  its  initial  public  offering  (the
     "IPO"),  selling  2,012,500 shares of common stock at a price of $18.50 per
     share  providing gross proceeds to the Company of $37,231 and net proceeds,
     after underwriting  discounts and commissions and offering expenses payable
     by the Company, of $33,508.

4.   Patent Litigation Settlement

     In July 1997,  the Company in  connection  with the  settlement  of certain
     pending patent  litigation  involving a United States patent  directed to a
     display  for  digital   dental   radiographs,   was  granted  a  worldwide,
     non-exclusive  fully paid license covering such patent in consideration for
     a payment by the Company of $600.  The Company  expensed the license fee in
     the quarter ended June 30, 1997.


                                       4
<PAGE>



                            Schick Technologies, Inc.
             Notes to Consolidated Financial Statements (unaudited)
               (In thousands, except share and per share amounts)
--------------------------------------------------------------------------------


5.   Earnings (Loss) Per Share

     Effective  December 31, 1997,  the Company  adopted  statement of Financial
     Accounting  Standards  No.  128,  "Earnings  per Share"  ("FAS  128") which
     requires presentation of basic earnings per share ("Basic EPS") and diluted
     earnings  per share  ("Diluted  EPS").  Basic EPS is  computed  by dividing
     income available to common stockholders by the  weighted-average  number of
     common shares  outstanding  during the period.  Diluted EPS gives effect to
     all dilutive  potential common shares  outstanding  during the period.  The
     computation  of  Diluted  EPS  does  not  assume  conversion,  exercise  or
     contingent exercise of securities that would have an antidilutive effect on
     earnings.  Earnings per share for the three-month period ended June 30,1997
     have been restated for the adoption of FAS 128. The adoption of FAS 128 did
     not have a  significant  impact on the loss per share for the period  ended
     June 30, 1997.

     The computation of basic earnings per share and diluted  earnings per share
     for the three-month periods ended June 30, 1998 and 1997 are as follows:

                                                Three months ended June 30,
                                                ---------------------------
                                                     1998          1997
                                                 -----------   -----------

     Net Income (loss) available to
        common stockholders                      $     1,483   $      (697)
                                                 ===========   ===========


     Weighted average shares outstanding
        for basic earnings (loss) per              9,992,477     7,957,231
        share
     Dilutive effect of stock options and
        warrants
                                                     383,023            --
                                                 -----------   -----------
     Weighted average shares outstanding
        for diluted earnings (loss) per           10,375,500     7,957,231
        share

     Basic earnings (loss) per share             $      0.15   $      (.09)
                                                 ===========   ===========
     Diluted earnings (loss) per share           $      0.14   $      (.09)
                                                 ===========   ===========

6.   Subsequent Event

     On July 14,  1998,  the  Company  invested an  additional  $250 in Photobit
     Corporation,   a  developer  of  complementary   metal-oxide  semiconductor
     ("CMOS"),  active-pixel  ("APS")  imaging  technology.  As of July 1998 the
     Company's investment in Photobit Corporation amounts to $1,250. The Company
     is the exclusive  licensee of the APS technology  for medical  applications
     and utilizes the  technology in both its  bone-mineral  density  assessment
     device and certain components of its computed dental x-ray imaging system.


                                       5

<PAGE>


Item 2. Management's  Discussion and Analysis of Financial Condition and Results
        of Operations

This Quarterly Report on Form 10-Q contains  forward-looking  statements  within
the  meaning of Section  27A of the  Securities  Act of 1933,  as  amended,  and
Section 21E of the Securities Exchange Act of 1934, as amended.  Actual results,
events and  circumstances  could differ  materially from those set forth in such
statements due to various  factors.  Such factors include the changing  economic
and competitive conditions in the medical and dental digital radiography market,
regulatory  approvals,  technological  developments,  protection  of  technology
utilized by the Company,  patent infringement  claims and other litigation,  and
further risks and  uncertainties,  including those detailed in Exhibit 99 hereto
and in the Company's other filings with the Securities and Exchange Commission.

General

The Company  designs,  develops and  manufactures  digital  imaging  systems and
devices  for the dental and  medical  markets.  In the field of  dentistry,  the
Company has developed,  and currently  manufactures  and markets,  an intra-oral
digital  radiography  system.  The  Company has also  developed  a bone  mineral
density assessment device to assist in the diagnosis of osteoporosis,  which was
introduced  in  December  of 1997.  The  Company is also  developing  large-area
radiographic imaging devices for digital mammography.

Results of Operations

Net revenue for the three months ended June 30, 1998,  increased  $10.0  million
(165%) to $16.0 million from $6.0 million during the comparable period of fiscal
1998.  The strong  growth is  attributable  to increased  sales of the company's
CDRTM dental  products  due to  increased  market  awareness,  broadening  sales
distribution, and increased demand in foreign markets combined with sales of the
Company's AccudexaTM bone mineral density assessment device which was introduced
in December 1997.

Cost of sales for the three months ended June 30, 1998,  increased  $4.4 million
(155%) to $7.2 million  (45.2% of net revenue)  from $2.8 million  (46.9% of net
revenue)  for the  comparable  period of fiscal  1998.  The decrease in Costs of
Sales as a  percentage  of revenue is  attributable  primarily to lower costs of
semiconductor wafers and decreased warranty costs.

Selling and  marketing  expenses  for the three  months  ending  June 30,  1998,
increased  $2.4 million  (132%) to $4.2 million (26.0% of net revenue) from $1.8
million  (29.7% of net revenue) for the comparable  period of fiscal 1998.  This
increase was  attributable  principally  to the hiring and training of new sales
representatives  as the Company  continued  to increase the size of its national
sales force and its promotional  programs to obtain greater market awareness and
to develop market strategies for new products.

General and  administrative  expenses  for the three months ended June 30, 1998,
increased $473 thousand  (53.9%) to $1.4 million (8.5% of net revenue) from $878
thousand  (14.5% of net revenue) for the  comparable  period of fiscal 1998. The
decrease as a  percentage  of sales was  attributable  primarily to increases in
sales of the Company's  products  partially  offset by increased  administrative
expenditures, primarily the hiring of administrative personnel.

Research  and  development  expenses  for the three  months ended June 30, 1998,
increased $395 thousand  (61.8%) to $1.0 million (6.5% of net revenue) from $638
thousand  (10.6% of net revenue) for the  comparable  period of fiscal 1998. The
increase in spending  reflects costs associated with research and development of
mammography  and panoramic  x-ray systems and the hiring of additional  research
and development personnel.

In July 1997, the Company,  in connection with the settlement of certain pending
patent  litigation  involving a United States  patent  directed to a display for
digital dental  radiographs,  was granted a worldwide,  non-exclusive fully paid
license  covering such patent in  consideration  for a payment by the Company of
$600  thousand.  The company  expensed that license fee during the quarter ended
June 30, 1997.


                                       6

<PAGE>


Interest  income  increased to $243  thousand in the three months ended June 30,
1998 from $48 thousand in the comparable  period of fiscal 1998. The increase is
attributable   to  higher  cash   balances   and   investments   in   short-term
interest-bearing  securities  that  were  purchased  with  the  proceeds  of the
Company's Initial Public Offering (the "IPO").  Interest expense of $43 thousand
for the three-month period ended June 30,1997 was principally attributable to a
loan from Merck & Co. Inc. that was repaid upon consummation of the IPO.

Liquidity and Capital Resources

Net proceeds from the July 1997 IPO were  approximately  $33.5 million.  At June
30,  1998,  the Company  had $1.6  million in cash and cash  equivalents,  $13.9
million in short-term  investments and $34.8 million in working capital compared
to $6.2  million  in cash and cash  equivalents,  $14.0  million  in  short-term
investments and $33.7 million in working capital at March 31, 1998.

During the quarter ended June 30, 1998, cash used in operations was $3.7 million
compared to $50 thousand  provided by operations during the comparable period of
fiscal 1998. The increased cash used in operations is primarily  attributable to
increases in the Company's  inventory  and accounts  receivable  resulting  from
increased  levels of operations and the timing of shipments to customers  during
the three months ended June 30, 1998.

The Company's capital expenditures during the quarter were $1.1 million. Capital
expenditures during the quarter included leasehold improvements,  computers, and
production  equipment.  The  Company's  planned  capital  expenditures  for  the
remainder of fiscal 1999 are $2.0  million,  primarily  for computer  equipment,
leasehold  improvements and production equipment.  Management currently believes
that  existing  capital   resources  are  adequate  to  meet  its  current  cash
requirements for 18-24 months. There can be no assurance,  however, that changes
in the Company's plans or other events  affecting the Company's  operations will
not result in accelerated or unexpected cash requirements.

Year 2000 Compliance

The Year 2000 issue is the result of computer  programs  being written using two
digits  rather than four to define the  applicable  year.  In other words,  date
sensitive  software may recognize a date using "00" as the year 1900 rather than
the year 2000. This could result in system failures or  miscalculations  causing
disruptions  of operation,  including,  among others,  a temporary  inability to
process  transactions,  send  invoices  or engage  in  similar  normal  business
activities.  The Company is  assessing  the  internal  readiness of its computer
systems and the  readiness of third  parties that  interact  with the  Company's
systems.  The Company  plans to devote the  necessary  resources  to resolve all
significant year 2000 issues in a timely manner.  Costs associated with the year
2000 assessment and correction of problems noted are expensed as incurred. Based
on management's  current  assessment,  it does not believe that the cost of such
actions will have a material  effect on the  Company's  results of operations or
financial condition.  The Company has not fully evaluated the impact of the Year
2000 issue on its suppliers and  customers.  The Company is currently  unable to
predict  the extent to which the Year 2000 issue will effect its  suppliers  and
customers,  or the extent to which it would be  vulnerable  to its  suppliers or
customers'  failure to remedy  Year 2000  issues on a timely  basis.  If a major
supplier or customer  fails to convert its systems on a timely basis the Company
could be materially adversely affected.


                                       7

<PAGE>


PART II OTHER INFORMATION

Item 2. Changes in Securities and Use of Proceeds

(d) On July 7, 1997, the Company's  initial public offering (the  "Offering") of
1,750,000  shares of its common  stock,  $.01 par value per share  (the  "Common
Stock") closed. The Company's  registration  statement on Form S-1 (Registration
No. 333-33731) was declared effective by the Securities and Exchange  Commission
on  June  30,  1997.  As  part  of the  Offering,  the  Company  granted  to the
Underwriters  over-allotment  options to purchase up to 262,500 shares of Common
Stock  ("the  "Underwriters'  Option").  On  July  10,  1997,  the  underwriters
exercised the  Underwriters'  Option  purchasing  262,500 shares of Common Stock
from the Company.  The aggregate  offering  price of 2,012,500  shares of Common
Stock  registered  for the  account  of the  Company  pursuant  to the  Offering
(inclusive of the Underwriters' Option) was $37,231.

     The aggregate net proceeds received by the Company from the Offering and as
a  result  of  the  exercise  of  the  Underwriters'   Option,  after  deducting
underwriting  and  commissions  and expenses were $33,508.  During the period of
July 1, 1997  through  June 30,  1998,  such net  proceeds  have been applied as
follows: (i) $1,113 for leasehold improvements; (ii) $3,935 for property, plant,
and equipment;  (iii) $1,450 to purchase certain assets of Keystone Dental X-Ray
Corp.;  (iv) $1,000 to purchase a 5% interest in Photobit,  Inc.;  (v) $1,513 to
pay the notes  payable  and the  interest  thereon  to Merck & Co.,  Inc.;  (vi)
$10,520 to short term investments;  (vii) $756 to money market investments;  and
(viii) the remaining $13,221 was used for working capital purposes.  None of the
net  proceeds  were  paid,  directly  or  indirectly,  to  directors,  officers,
controlling stockholders or affiliates of the Company.

Item 6. Exhibits and Reports on Form 8-K.

(a)  Exhibits

     (27) Financial Data Schedule

                                       8

<PAGE>

                            SCHICK TECHNOLOGIES, INC.
                                    SIGNATURE

Pursuant  to the  requirement  of the  Securities  Exchange  Act  of  1934,  the
registrant  has duly  caused  this  Report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.


                                               SCHICK TECHNOLOGIES, INC.



Date: August 13, 1998                      By: /s/ David B. Schick      
                                               -------------------------------
                                               David B. Schick
                                               President and
                                               Chief Executive Officer


                                           By: /s/ Thomas E. Rutenberg   
                                               -------------------------------
                                                   Thomas E. Rutenberg
                                                   Director of Finance
                                                   (Principal Financial Officer)

                                       9